- All Systems Go ODMA 2015
- Aviva and Clic Part Company
- A Virtual Reality Approach to...
- New Kid on PI Block
- Women Over 40 At Greater Risk of...
- Simple Therapy Could Cure Colour...
- Deafblind PIN Access to Telcos
- New Drug Class for Retinoblastoma
The Changing Face of Continuing ...
Five years ago, continuing professional development for optometry was preferred but not required. Five years ago, optometrists had around 300 CPD activities a year to choose from.Today optometrists... More
2TCPD Pts: Keratitis Management ...
Optometrists play a vital role in differentiating corneal infection from sterile corneal inflammation, as well as educating vulnerable groups on the risks of developing this sight-threatening ocular... More
2TCPD Pts: Anti-VEGF Therapy...
Anti-vascular endothelial growth factor (VEGF) agents have revolutionised the treatment of neovascular age-related macular degeneration (nvAMD). While new treatments are under development, currently... More
The Counter-Culture of Seeking...
Say the word ‘feedback’ and you get an immediate reaction. Whether it’s the challenge of giving it or receiving it, feedback is tricky territory all too often avoided. The problem... More
Lucentis on PBS for DME and RVO
The Federal Government has placed the registered drug ranibizumab (Lucentis) on the Pharmaceutical Benefits Scheme (PBS), enabling affordable access to treatment for Diabetic Macular Edema (DME) and Retinal... Read More
Refining Treatments for Macular Disease
As the incidence of macular disease continues to increase along with options for treating the disease, Professor Mark Gillies reviews the latest research from the clinical, observational and laboratory study... Read More
Eyecare Plus New GM and Move to Sydney
Eyecare Plus will move its national office to Sydney and operate under the direction of Simon Lewis as the organisation’s new general manager. Mr. Lewis has vast experience across the optometry industry... Read More